SeaStar Medical Holding Co. (NASDAQ:ICU) Sees Large Increase in Short Interest

SeaStar Medical Holding Co. (NASDAQ:ICU) saw a significant growth in short interest in the month of June. As of June 15th, there was short interest totalling 117,100 shares, a growth of 207.3% from the May 31st total of 38,100 shares. Based on an average daily trading volume, of 217,300 shares, the days-to-cover ratio is presently 0.5 days. Currently, 4.3% of the shares of the company are short sold.

SeaStar Medical Stock Performance

Shares of ICU stock traded down $0.67 during mid-day trading on Thursday, reaching $6.89. 293,438 shares of the company’s stock traded hands, compared to its average volume of 239,193. SeaStar Medical has a 12 month low of $3.25 and a 12 month high of $42.92. The firm has a 50 day moving average price of $8.76 and a two-hundred day moving average price of $14.73. The firm has a market capitalization of $20.81 million, a PE ratio of -0.28 and a beta of -1.03.

SeaStar Medical (NASDAQ:ICU) last posted its quarterly earnings data on Tuesday, May 14th. The company reported ($4.75) EPS for the quarter.

SeaStar Medical Company Profile

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.